Photo: Depositphotos
Aug 4, 2025, 07:28
Oscar Tahuahua: ROS1+ had the Highest Thromboembolic Event Risk in Lung Adenocarcinoma
Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a recent article by Xiaohan Qian et al, on X, adding:
“Retrospective study (n=546): in adv. Lung adeno, ROS1+ had the highest thromboembolic event (TE) risk (32.5% overall, 17.5% peri-dx), followed by RET+ (21.7%) & ALK+ (19.5%). Only ROS1+ remained significant in multivariate. TE ↓ OS in EGFR+. Prophylaxis?”
Title: The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study
Authors: Xiaohan Qian, Mengjiao Fu, Jing Zheng, Junjun Chen, Cuihong Cai, Jianya Zhou, Jianying Zhou
More posts featuring Oscar Tahuahua.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 4, 2025, 07:01
Aug 4, 2025, 06:55
Aug 4, 2025, 06:09
Aug 4, 2025, 06:04
Aug 4, 2025, 05:55
Aug 4, 2025, 05:26
Aug 4, 2025, 05:17